Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ -60,140
▼ 6149% vs 2024
Profit
Caution€ -483,778
▼ 1651% vs 2024
Debts
Low€ 155,539
▲ 118% vs 2024
PhiDeX Inc. from Sint-Martens-Latem, company number BE0563943350, closed financial year 2025 with a result of € -483,778 after tax. For that financial year PhiDeX Inc. recorded a gross margin of € -60,140 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 31,186 to € -483,778. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.
What happened at PhiDeX Inc.?
What happened at PhiDeX Inc. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 483,778 (▼ 1651% vs 2024). Source: NBB ↗
- Johan Lamoot became a director. NBB
- NESCH INVEST BV became a director. NBB
- New establishment in Sint-Martens-Latem. KBO
- Start of the company according to the CBE. KBO
In short
From € 496,871 loss in 2021 to € 483,778 loss in 2025.
Paid € 57,637 in corporate taxes since 2021.
Best year ever: 2024, with € 31,186 profit.
A new publication or filing at PhiDeX Inc.? We notify you, reason included.
Follow PhiDeX Inc.Need more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind PhiDeX Inc. are Johan Lamoot and NESCH INVEST BV. It owns 68.6% of EPM PHARMA INVEST, 65.7% of B+INVEST2, 28.7% of PHIDEX CALN and 28.6% of RXW GROUP itself.
Directors
According to the 2025 annual accounts
since 2021
Director · represented by Geert Van Gijseghem
Also active at: MAB Consult Europe, RXW Group, EPM Pharma Invest +6 more
since 2020
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 180 box 4C
9830 Sint-Martens-Latem
Kortrijksesteenweg 180 box 4c
9830 Sint-Martens-Latem
Active since 13 October 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
ADMISOL
€ 1.6 million gross margin · 2025
MAB Consult Europe same network
€ -849 gross margin · 2025
CASA GRANDE
€ 373,195 gross margin · 2025
RXW Group same network
€ -140,092 gross margin · 2025
EPM Pharma Invest same network
€ -66 gross margin · 2025
+11 more
Details
- Company number
- 0563.943.350
- VAT number
- BE 0563.943.350
- Registered office
- Kortrijksesteenweg 180 bus 4C, 9830 Sint-Martens-Latem
- Names & denominations
- PhiDeX Inc.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 October 2014
- Peppol
- Active · Active since 2 Jun 2026
- Contact
- phidex.eu info@phidex.eu
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van holdings
Holdings